In the latest trading session,, 7.14 million Hims & Hers Health Inc (NYSE:HIMS) shares changed hands as the company’s beta touched 2.10. With the company’s most recent per share price at $55.23 changed hands at -$1.1 or -1.95% at last look, the market valuation stands at $12.36B. HIMS’s current price is a discount, trading about -32.14% off its 52-week high of $72.98. The share price had its 52-week low at $13.47, which suggests the last value was 75.61% up since then.
Analysts gave the Hims & Hers Health Inc (HIMS) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.40. If we narrow down to specifics, the data shows that 0 out of 13 analysts rate the stock as a Sell, with a further 1 assigning it an Overweight rating. Of the remaining, 5 recommended HIMS as a Hold, 7 felt it is a Buy and 0 rated the stock as Underweight. Hims & Hers Health Inc’s EPS for the current quarter is expected to be 0.22.
Hims & Hers Health Inc (NYSE:HIMS) trade information
Instantly HIMS was in red as seen in intraday trades today. With action -2.71%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 128.41%, with the 5-day performance at -2.71% in the red. However, in the 30-day time frame, Hims & Hers Health Inc (NYSE:HIMS) is 7.45% up.
The consensus price target for the stock as assigned by Wall Street analysts is 66.5, meaning bulls need an upside of 16.95% from its recent market value. According to analyst projections, HIMS’s forecast low is 65 with 68 as the target high. To hit the forecast high, the stock’s price needs a -23.12% plunge from its current level, while the stock would need to soar -17.69% for it to hit the projected low.
Hims & Hers Health Inc (HIMS) estimates and forecasts
Year-over-year growth is forecast to reach 58.81% up from the last financial year.
Consensus estimates given by 9 financial analysts project the company’s revenue in the current quarter to hit an average of 550.06M. 9 analysts are of the opinion that Hims & Hers Health Inc’s revenue for the current quarter will be 587.04M. The company’s revenue for the corresponding quarters a year ago was 315.65M and 401.56M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 74.26%. The estimates for the next quarter sales put growth at 46.19%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 17.22%. The 2025 estimates are for Hims & Hers Health Inc earnings to increase by 24.89%, but the outlook for the next 5-year period is at 34.57% per year.
HIMS Dividends
Hims & Hers Health Inc is expected to release its next quarterly earnings report in July.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 6.7907% or 14.57 million shares worth $294.25 million as of 2024-06-30.
Among Mutual Funds, the top two as of Apr 30, 2025 were iShares Trust-iShares Core S&P Mid-Cap ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund . With 6.19 shares estimated at $341.4 million under it, the former controlled 2.87% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held about 2.54% of the shares, roughly 5.47 shares worth around $301.43 million.
